[1] Dewire S M,Ahn S,Lefkowitz R J,et al.Beta-arrestins and cell signaling[J]. Annual Reviewof Physiology,2007,69:483-510. [2] McDonald P H,Chow C W,Miller W E,et al.Beta-arrestin 2:a receptor-regulated MAPK scaffold for the activation of JNK3[J]. Science,2000,290(5496):1574-1577. [3] Luan B,Zhao J,Wu H,et al.Deficiency of a β-arrestin-2 signal complex contributes to insulin resistance[J]. China Basic Science,2010,457(7233):1146-1149. [4] 裴刚. β-arrestin2 在Ⅱ型糖尿病致病机理中的作用[J].中国基础科学,2010,12(1):3-5. [5] Lenhard J M,Gottschalk W K.Preclinical developments in type 2 diabetes[J]. Advanced Drug Delivery Reviews,2002,54(9):1199-1212. [6] 陈冠军,邢金良,商彭,等.外源基因在大肠杆菌中表达效率的影响因素[J].世界最新医学信息文摘,2004, 3(3):1121-1124. [7] Su Z,Huang Y,Zhou Q,et al.High-level expression and purification of human epidermal growth factor with SUMO fusion in Escherichia coli[J]. Protein and Peptide Letters,2006,13(8):785-792. [8] Zuo X,Mattern M R,Tan R,et al.Expression and purification of SARS coronavirus proteins using SUMO fusions[J]. Protein Expression and Purification,2005,42(1):100-110. [9] Malakhov M P,Mattern M R,Malakhova O A,et al.SUMO fusion and SUMO-specific protease for efficient expression and purification of proteins[J]. Journal of Structural and Functional Genomics,2004,5(1/2):75-86. [10] Butt T R,Edavettal S C,Hall J P,et al.SUMO fusion technology for difficult-to-expression proteins[J]. Protein Expression and Purification,2005,43(1):1-9. [11] Marblestone J G,Edanettal S C,Lim Y,et al.Comparison of SUMO fusion technology with traditional gene fusion systems: Enhanced expression and solubility with SUMO[J]. Protein Science,2006,15(1):182-89. |